Waters Flagship ARES‑G3 Rheometer Sets New Benchmark for Data Quality at Breakthrough Speed
Rhea-AI Summary
Waters (NYSE: WAT) launched the ARES-G3 Rheometer on March 9, 2026, a next-generation TA Instruments product that boosts data capture and speeds up testing.
The instrument captures up to 25,000 data points per second, delivers up to 10x the data rate of its predecessor, and can cut standard test times by up to 80%, enabling faster workflows and reduced calibrations.
Positive
- Data capture up to 25,000 points/sec (10x predecessor)
- Standard test times reduced by up to 80%, e.g., six hours to one
- Fewer user calibrations required, lowering human-error risk
- Full compatibility with existing ARES-G2 methods and fixtures
Negative
- None.
News Market Reaction – WAT
On the day this news was published, WAT gained 1.03%, reflecting a mild positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
WAT fell 4.14% while key peers were mixed to lower: PKI was flat, DGX, ILMN, LH, and MTD declined between about 1–3%, indicating WAT weakness is more stock-specific than a broad sector move.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Feb 23 | Conference appearance | Neutral | -0.5% | Announcement of CEO fireside chat at TD Cowen Health Care Conference. |
| Feb 17 | Product launch | Positive | -0.6% | Launch of new microflow LC columns with higher sensitivity and lower usage. |
| Feb 9 | M&A completion | Positive | -13.9% | BD completes spin-off and combination of its business with Waters. |
| Feb 9 | M&A completion | Positive | -13.9% | Waters completes combination with BD units, forming four new divisions. |
| Feb 9 | Earnings results | Positive | -13.9% | Q4 and 2025 results with higher sales and EPS plus 2026 guidance. |
Recent history shows multiple positive strategic and product updates followed by negative price reactions, suggesting a pattern of selling into good news.
Over the last months, Waters reported strong Q4 2025 and full-year results with higher sales and EPS, and issued detailed 2026 revenue and EPS guidance. The company also closed a major combination with BD’s Biosciences & Diagnostic Solutions businesses, creating four organized divisions, but shares dropped 13.94% on that cluster of announcements. Additional product launches, such as MaxPeak Premier LC columns, and a conference appearance in late February also saw small negative reactions. Today’s ARES-G3 rheometer launch continues the stream of innovation-focused news against a weaker share-price backdrop.
Market Pulse Summary
This announcement highlights Waters’ push to enhance materials characterization with the ARES-G3 rheometer, which delivers up to 25,000 data points per second and cuts standard test times by up to 80%. It builds on the ARES-G2 platform while remaining compatible with existing methods and fixtures. In the context of recent product launches, major M&A with BD’s businesses, and solid 2025 earnings, this news adds to the company’s innovation pipeline. Investors may watch adoption trends and any follow-on updates around performance and customer demand.
Key Terms
rheometer technical
rheology technical
dynamic mechanical analysis technical
AI-generated analysis. Not financial advice.
News Summary:
- Reduces standard testing times by
80% .1 - Delivers an industry-leading 25,000 data points per second, detecting transient material behaviors previously invisible to measurement. 2
- Operates with fewer calibrations and superior atmosphere and temperature control. 3
"Rheology labs are under enormous pressure to deliver better data, faster, to unlock breakthroughs and support business decisions," said Dan Rush, Senior Vice President, Waters Materials Sciences, Waters Corporation. "We're pleased to deliver a cutting-edge instrument that can provide unique data in record time, providing novel insights and empowering our customers to meet these increasing demands."
The ARES-G3 Rheometer enables shortened experiment times, increased lab throughput, and previously unobtainable measurements of fast-changing samples in a single test. Because it fully integrates a Fast Frequency Chirps solution into its enhanced TRIOS™ Software, the ARES-G3 Rheometer eliminates the need for multiple software licenses and training in advanced programming packages to capture and process data through rapid frequency sweeps. Routine quality control tests and data generation can also be completed up to
"For years, rheologists have struggled to capture in-depth data on materials that are actively curing or degrading. The kinetics are so fast that conventional rheometers miss the critical information," said Chris Macosko, Ph.D., Professor Emeritus, Department of Chemical Engineering and Materials Science, University of Minnesota. "Integrating Fast Frequency Chirps and precise temperature control means we can now generate time-temperature-dependent data in one-fifth of the usual time. The new ARES-G3 Rheometer delivers the accurate and consistent data that we need to succeed."
The ARES-G3 Rheometer builds on the flagship legacy of its predecessor, improving at-instrument control with a new touchscreen, enhancing data capture with hardware and software updates, and preserving its core proprietary, fully integrated dynamic mechanical analysis (DMA) capabilities and purpose-built hardware for both stress measurement and strain control. Retaining the best-in-class oven of the ARES-G2 Rheometer, this next-generation rheometer delivers leading low-oxygen atmosphere control and temperature uniformity, further simplifying the process of simulating real‑world processing conditions, and enabling scientists to explore new rheological methods and gain a deeper understanding of structure-property relationships.
All existing ARES-G2 Rheometer methods and fixtures remain fully compatible with the ARES-G3 Rheometer. The Waters TA Instruments ARES‑G3 Rheometer is available for order today.
Additional Resources:
Waters, ARES, TRIOS, and TA Instruments are trademarks of Waters Corporation or its affiliates. All other marks are the property of their respective owners.
About: Waters Corporation (NYSE: WAT) is a global leader in life sciences and diagnostics, dedicated to accelerating the benefits of pioneering science through analytical technologies, informatics, and service. With a focus on regulated, high-volume testing environments, our innovative portfolio harnesses deep scientific expertise across chemistry, physics, and biology. We collaborate with customers around the world to advance the release of effective, high-quality medicines, ensure the safety of food and water, and drive better patient outcomes by detecting diseases earlier, managing routine infections, and combating antibiotic resistance. Through a shared culture of relentless innovation, our passionate team of ~16,000 colleagues turn scientific challenges into breakthroughs that improve lives worldwide. For more information, please visit www.waters.com/about.
References:
1 When using Fast Frequency Chirps compared to standard master curve and frequency sweep test methods.
2 When compared to the ARES-G2 Rheometer.
3 When compared to conventional, combined-motor-transducer (CMT) rheometers and oven accessories.
Contact:
Molly Gluck
Head of External Communications
Waters Corporation
+1.508.498.9732
molly_gluck@waters.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/waters-flagship-aresg3-rheometer-sets-new-benchmark-for-data-quality-at-breakthrough-speed-302708099.html
SOURCE Waters Corporation
FAQ
What speed and data rate does the ARES-G3 Rheometer (WAT) achieve?
How much faster are tests on the ARES-G3 compared with previous rheometers?
Does the ARES-G3 Rheometer require additional software licenses for Fast Frequency Chirps?
Are existing ARES-G2 methods and fixtures compatible with the ARES-G3 (WAT)?
What laboratory benefits does the ARES-G3 offer for materials research and QC?
